Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,689 | -93,796 | -29,047 | -106,908 | -53,417 |
| Depreciation Amortization | -3,236 | -5,514 | -255 | 1,584 | 897 |
| Income taxes - deferred | N/A | N/A | 3,620 | -2,208 | -1,280 |
| Accounts receivable | 2,716 | -216 | -1,385 | 2,998 | -2,947 |
| Accounts payable and accrued liabilities | 1,229 | 1,934 | -1,348 | 152 | 17 |
| Other Working Capital | -14,057 | -55,183 | 4,405 | 6,998 | 43,701 |
| Other Operating Activity | 21,592 | 25,617 | 24,332 | 11,588 | 6,945 |
| Operating Cash Flow | $-76,445 | $-127,158 | $322 | $-85,796 | $-6,084 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 49,468 | 79,979 | -175,176 | -26 | -7,526 |
| PPE Investments | N/A | -1,938 | -602 | -1,650 | -2,237 |
| Investing Cash Flow | $49,468 | $78,041 | $-175,778 | $-1,676 | $-9,763 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 542 | 842 | 880 | 95,557 | 247,842 |
| Financing Cash Flow | $542 | $842 | $880 | $95,557 | $247,842 |
| Exchange Rate Effect | -116 | 22 | -330 | -54 | -604 |
| Beginning Cash Position | 111,268 | 159,521 | 334,427 | 326,396 | 95,005 |
| End Cash Position | 84,717 | 111,268 | 159,521 | 334,427 | 326,396 |
| Net Cash Flow | $-26,551 | $-48,253 | $-174,906 | $8,031 | $231,391 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,445 | -127,158 | 322 | -85,796 | -6,084 |
| Capital Expenditure | N/A | -1,938 | -602 | -1,690 | -2,237 |
| Free Cash Flow | -76,445 | -129,096 | -280 | -87,486 | -8,321 |